AllDocs -> cancers

New and Emerging Technology Briefing G17DT for pancreatic, stomach and colorectal cancer January 2003 Horizon Scanning Review Early assessments of new or emerging technologies contain time-limited information and should be used with due caution. Not to be used for commercial purposes National Horizon Scanning Centre Page 2 National Horizon Scanning Centre G17DT Jnauary 2003 2 G17DT for pancreatic, stomach and colorectal cancer Summary G17DT is a vaccine that neutralises gastrin-17, a hormone required for the growth of a number of cancers of the gastrointestinal tract. It is in phase III trials for advanced pancreatic cancer as a monotherapy and in combination with gemcitabine. It is also in a phase II/III trial for advanced stomach cancer ...

KIMBA ROXBY DOWNS (M) COOBER PEDY (DC) UNINCORP. FAR NORTH UNINCORP. FLINDERS RANGES ROBE BERRI CLARE HAWKER CEDUNA TANUNDA WHYALLA MENINGIE WILLUNGA MAITLAND PORT PIRIE BORDERTOWN PORT LINCOLN PETERBOROUGH PORT AUGUSTA MOUNT GAMBIER PORT BROUGHTON 0 100 200 50 Kms Stomach Cancer Mortality in South Australia, 1991-2000 by Statistical Local Areas GAWLER GLENELG MODBURY WILLUNGA ADELAIDE WOODVILLE ELIZABETH MOUNT BARKER BEDFORD PARK NOARLUNGA CENTRE Annual Mortality/100,000 0.0 - 2.5 2.6 - 5.0 5.1 - 7.5 7.6 - 30.0 Towns Statistical Local Areas Produced by: Data Analysis and Consulting Unit, Information Management Services, and Epidemiology Branch, Department of Human Services. Data Sources: Cancer ...

Annual cancer incidence and death rates per 100,000 South Australians by age, 1991-2001 Cancer site: Stomach Males 0.0 50.0 100.0 150.0 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80* Age (yrs.) R a te/ 1 00, 000 Incidence Mortality Females 0.0 10.0 20.0 30.0 40.0 50.0 60.0 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80* Age (yrs.) R a te/ 100, 000 Incidence Mortality Both 0.0 10.0 20.0 30.0 40.0 50.0 60.0 70.0 80.0 90.0 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80* Age (yrs.) R a te/ 100, 000 Incidence Mortality ...

KIMBA ROXBY DOWNS (M) COOBER PEDY (DC) UNINCORP. FAR NORTH UNINCORP. FLINDERS RANGES ROBE BERRI CLARE HAWKER CEDUNA TANUNDA WHYALLA MENINGIE WILLUNGA MAITLAND PORT PIRIE BORDERTOWN PORT LINCOLN PETERBOROUGH PORT AUGUSTA MOUNT GAMBIER PORT BROUGHTON 0 100 200 50 Kms Incidence of Stomach Cancer in South Australia, 1991-2000 by Statistical Local Areas GAWLER GLENELG MODBURY WILLUNGA ADELAIDE WOODVILLE ELIZABETH MOUNT BARKER BEDFORD PARK NOARLUNGA CENTRE Annual Incidence/100,000 0.0 - 2.5 2.6 - 5.0 5.1 - 7.5 7.6 - 30.0 Towns Statistical Local Areas Produced by: Data Analysis and Consulting Unit, Information Management Services, and Epidemiology Branch, Department of Human Services. Data Sources: ...

2003 alPHa RESOLUTION NO. A03-3 TITLE: Heliobacter Pylori and Gastric Cancer Prevention SPONSOR: Regional Municipality of Durham WHEREAS stomach cancer is the second leading cause of cancer- related mortality worldwide; and WHEREAS the outcome of treatment for stomach cancer is poor; and WHEREAS H. pylori is associated with some stomach cancers; and WHEREAS the International Agency for Research on Cancer has designated H. pylori as a Class 1 human carcinogen; and WHEREAS H. pylori infects a substantial proportion of Canadians; and WHEREAS H. pylori is commonly acquired in childhood, usually by ten years of age, and will persist life-long unless treated; and WHEREAS H. pylori can be detected by non-invasive tests (i.e., serology and urea breath test); and WHEREAS H. pylori can be effectively eradicated by medical treatment (i.e., triple therapy – two anti- microbial ...

Center for Environmental Health Studies (617) 482-9485 44 Farnsworth Street, Boston, MA 02210 http://www.jsi.com * Findings were statistically significant (strong evidence) + Evidence of a dose-response relationship (strongest evidence) Page 92 Stomach Cancer and Exposure to Ionizing Radiation Summary: Moderately strong evidence has been recorded of a possible connection between stomach cancer and exposure to ionizing radiation. This evidence is based upon studies of nuclear workers exposed to ionizing radiation. These findings are consistent with the National Research Council’s determination that the stomach is sensitive to ionizing radiation. Stomach cancer is designated as a “specified” cancer under the Energy Employees Occupational Illness Compensation Program Act. Historically, stomach cancer incidence and mortality ...

A fact sheet from the Greater Bay Area Cancer Registry Stomach Cancer in the Greater San Francisco BayArea 1988-2000 March 2003 Despite declining incidence and mortality rates in the last few decades, stomach cancer ( also referred to as gastric cancer) is still a common cancer worldwide, second only to lung cancer. In the US, stomach cancer is more common among racial/ethnic minority groups; it is the fifth most common cancer in black, Hispanic, and Asian/Pacific Islander males. Figure 1. Age-adjusted incidence and mortality rates for stomach cancer by year of diagnosis, Greater San Francisco Bay Area, 1988-2000 Figure 2. Age-adjusted stomach cancer incidence by race/ethnicity, Greater San Francisco Bay Area, 1988-2000 0 2 4 6 8 10 12 14 16 18 20 1988 1989 1990 ...

Although men have a higher incidence and mortality rate from stomach cancer than women, the time trends for both genders are similar. For both men and women incidence and mortality has decreased by 20-35% over the last 20 years. Background notes Stomach Cancer Page 2 Male Stomach Cancer - Incidence and Mortality* 1977-2000 All Ages Source - SA Cancer Registry 0 4 8 12 16 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 Year *Age Standardised for World Population R a t e / 1 0 0 0 0 0 Incidence Mortality Male Stomach Cancer Incidence and Mortality* 1977-2000 All Ages Source: SA Cancer Registry Data ...

EXPERIMENTAL and MOLECULAR MEDICINE, Vol. 33, No. 1, 15-19, March 2001 Post-transcriptional control of c- erb B-2 overexpression in stomach cancer cells Chang-Dae Bae 1 , Yong-Sung Juhnn 2 and Joo-Bae Park 1,3 1 Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon 440-746, Kyungkido, Korea 2 Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul 110-799, Korea 3 Corresponding author: Tel, +82-31-299-6130; Fax, +82-31-299-6149; E-mail, jbpark@med.skku.ac.kr Accepted 26 February, 2001 Abbreviations: UTR, untranslated region; Met, methionine; FBS, fetal bovine Abstract The growth factor receptor oncogene, c-erb B-2, is frequently overexpressed in the adenocarcinomas ...

All-Ireland cancer statistics 1994-96 35 Stomach 4. MALIGNANT CANCER OF THE STOMACH ICD-O.2 C16 ICD-10 C16 ICD-9 151 Key facts • Average of 731 new cases per year, 1994-96: 268 in females, 463 in males. • Average of 600 deaths per year: 242 in females, 358 in males. • Age-standardised incidence and mortality rates about twice as high in males as in females. • 6th most common site for cancer incidence in males, 7th in females. • 4th most common cause of cancer deaths in males, 6th in females. • Higher incidence rate, by about 18%, among males in Northern Ireland (NI) than in the Republic (RoI). • Higher incidence rates in urban compared with other populations, by about 37% (females), 39% (males). • All-Ireland incidence rates for both males and females lower than the EU average. Summary statistics ...

cancer 1126 Practical 2: Analysis of general clustering and point source investigations using the Splus software Introduction In this practical you will be using the Splus software to carry out some of the tests for disease clustering and investigation of disease risk around a point source that were discussed in the lecture. Splus is a commercial software package for data analysis and graphical display; it also provides an object-oriented programming language. During the practical, you will be using Splus to produce graphical displays of the data to help visualise e.g. locations of possible disease clusters and relationships between disease risk and distance from a point source, and to carry out data manipulation and regression analysis using standard Splus functions. We have also written a library of functions using the Splus programming language to implement some of the statistical methods for cluster and point source ...

In the 1970s, when he worked as a pathologist in the Colombian city of Cali, Pelayo Correa noticed that migrants from the state of Nariño in the country’s southwest seemed prone to st omach ca ncer. La ter studies showed that these people indeed are five times as likely to get the disease as other Colombians are. Now at Louisiana State University (LSU) in New Orleans, Correa has come up with a way to derail incipient st omach ca ncer as it marches through its predictable stages of aberrant cell growth in the st omach li ning. Correa and his colleagues in Colombia and at LSU report in the Dec. 6 J OURNAL OF THE N ATIONAL C ANCER I NSTITUTE that antibiotics, vitamin C, or beta-carotene—a precursor of vitamin A—can reverse precancerous st omach co nditions. In 1992, the researchers began taking st omach bi opsies of more than 1,200 Nariño adults. They ...

stomach cancer 1438 SMR_Stomach_Ca A B C D E F G H I J K L M N O P 1 Department of Health 2 Compendium of Clinical and Health Indicators 1999 3 Centre for Public Health Monitoring 4 London School of Hygiene ...

stomach cancer 1438 YLL_stomach_ca A B C D E F G H I J K L M 1 Department of Health 2 Compendium of Clinical and Health Indicators 1999 3 Centre for Public Health Monitoring 4 London School of Hygiene and Tropical Medicine ...

stomach cancer 1438 SRR_Stomach_Ca A B C D E F G H I J K L M N O P 1 Department of Health 2 Compendium of Clinical and Health Indicators 1999 3 Centre for Public Health Monitoring 4 London School of Hygiene ...

A BASIC INFORMATION DESCRIPTION Uncontrolled growth of malignant cells in the st omach. It affects adults over age 40 and is twice as common in men as women. Unfortunately, most people do not have symptoms until the disease is advanced. It is com- mon in Japan. FREQUENT SIGNS AND SYMPTOMS Early stages: • Vague symptoms of indigestion, such as fullness, burping, nausea and poor appetite. Later stages: • Unexplained weight loss. • Loss of appetite. • Vomiting blood. • Black stools. • Fullness after eating small amounts. • Anemia. • Pain in the upper abdomen. • Mass in the upper abdomen that can be felt (some- times). CAUSES Unknown. Evidence suggests that a lack of fresh fruits and vegetables may be a factor. RISK INCREASES WITH • Males over age 40. • Family history of st omach ca ncer. • Pe rnicious anemia. • Excess ...

Oesophago-gastric Cancer Centre Addenbrooke’s Hospital Papworth Hospital Date: 14 February 2005 File: PI 122 Page 1 of 3 Frequently asked questions about cancer of the stomach You have recently had some tests that tell us that you have a cancer in your stomach . We hope this information will help answer some of your questions – if you have any concerns and worries, please do not hesitate to ask us. We want you to understand what is happening so you can make informed decisions about what we do next for you. Where is the stomach and what does it do? The stomach is a J-shaped ‘bag’, which acts as a temporary storage area for any food and drink that you eat. It lies just below the diaphragm in your abdomen (tummy) and is next to your liver, gall bladder, spleen and pancreas. From above it, in the chest, the oesophagus (gullet) squeezes food and drink into the ...

M o st P r osperous C oast and C ountry S e rvices and E ducation G r ow th A r eas R e sort and R e tirem ent M i xed U rban and R u ral M i xed E conom ies Inner London M anufacturing C oalfields P o rts and Industry 0 50 100 150 200 SRR and 95% confidence intervals (England and Wales = 100) ONS area classification groups England Health Authorities (1996 boundaries) ONS area values (these are derived from LA data and may not therefore reflect the mean for constituent HAs) Indirectly standardised registration ratios for males (all ages), 1990 to 1992 Incidence of stomach cancer:

M ost Prosperous C oast and C ountry Services and Education G r ow th Areas R esort and R e tirem ent M i xed U r ban and R u ral M i xed Econom ies Inner London M anufacturing C oalfields Ports and Industry 0 50 100 150 200 SRR and 95% confidence intervals (England and Wales = 100) Indirectly standardised registration ratios for females (all ages), 1990 to 1992 ONS area classification groups Incidence of stomach cancer: England Health Authorities (1996 boundaries) ONS area values (these are derived from LA data and may not therefore reflect the mean for constituent HAs)

STOMACH CANCER FORM Please do your best to fill out this form as accurately as possible. We will notifiy when the announement is posted. Please make sure you check your spelling. In completing this stomach cancer form please fill out complete names In Address and locations, please give city state and zip. Date you want stomach cancer to come out_ stomach cancer will not be published until receive a date. If partners are available please list full names of all partners involved Full names and address of stomach cancer _ Partners (include address) __ other partners (include address)__ Are the stomach cancer partners on the Internet? Yes_ No__ If no list the relationship of the stomach cancer __ Company been in business for how long?__ Partner employed by NAME AND DAYTIME NUMBER (WITH AREA CODE) OF A PERSON AVAILABLE TO ANSWER QUESTIONS I certify to the best ...

Abstract. CDX2, a transcriptional factor expressed in the intestine, is implicated in the development and maintenance of the intestinal mucosa. Recent studies have demonstrated that CDX2 is expressed in the intestinal metaplasia of the stomach and intestinal-type gastric cancer, while it is not expressed in the normal gastric mucosa. To investigate the role of CDX2 in gastric cancer, we determined CDX2 expression and cell proliferation rate in various types of gastric cancer tissues by immunostaining. Surgically dissected gastric cancer tissues were collected from 40 patients. Consistent with previous reports, CDX2 was expressed in most gastric mucosa samples with intestinal metaplasia (89%, 16/18), although it was not found in the adjacent normal mucosa. CDX2 expression was also detected in 64% (18/28) of intestinal- type gastric cancer cases, whereas it was not observed in the diffuse-type ...

l del file contenuto in http://www.ultrasound.or.kr/workshop/2001s/abstract/files/32p00069.ppt . G o o g l e crea automaticamente la versione .html dei documenti durante la scansione del Web. Per inserire un segnalibro o un collegamento alla pagina, utilizzare il seguente URL: http://www.google.com/search?q=cache:ieIe4vU6AGEJ:www.ultrasound.or.kr/workshop/2001s/abstract/files/32p00069.ppt+allintitle:+stomach+cancer+filetype:pdf+OR++filetype:doc+OR+filetype:ppt+OR++filetype:xls+OR+filetype:rtf&hl=it&lr=lang_en Google non è collegato agli autori di questa pagina e non è responsabile del suo contenuto. I termini specificati sono presenti solamente in collegamenti che rimandano alla seguente pagina: allintitle stomach cancer 1581 Soft-Tissue Hemangioma and Vascular Malformation : Ultrasonographic Differentiation Department of Diagnostic Radiology, College of Medicine, Dong-A University HS Shin, JY ...

ON1045A What Is Stomach ( Gastric) Cancer? Cancer occurs when cells in the body begin changing and multiplying out of control. These cells can form lumps of tissue called tumors. Cancer that forms in the stomach is called stomach or gastric cancer. Understanding the Stomach The stomach helps the body digest food. When food is swallowed, it travels down a tube called the esophagus. The esophagus ends in the stomach. The stomach adds chemicals and fluids to food that help begin the process of digestion. Food then leaves the stomach and enters the small intestine. When Stomach Cancer Forms In most cases, stomach cancer starts in the stomach’ s inner lining, the mucosa. Cancer cells can then spread through the other layers of the stomach. If cancer cells reach the stomach’ s outer layer, they can invade nearby organs. Stomach ...

Gastric carcinogenesis involves a multistep and multifactorial process from a normal mucosa to chron- ic gastritis, atrophic gastritis, intestinal metaplasia and dysplasia (1, 2). Histologic precancerous lesions are frequently observed in the gastric stump after subtotal resection for benign gastroduodenal disease and in the stomach affected by Helicobacter pylori (H. pylori) infection. Hemigastrectomy has been also suggested as a risk factor for subsequent gastric cancer ( 3). Many functional and anatomic modifications may be regarded as risk factors in the carcinogenesis of the gastric remnant (4-6). More recently, an association between H. pylori and precancerous gastric lesions has been demonstrat- ed (7, 8) and H. pylori has been classified as "a defi- nite carcinogen" at the 1994 WHO/IARC meeting (9). Therefore, hemigastrectomy and H. pylori infection may be considered as causal ...

A209: Stomach cancer tissues (formalin fixed) For research use only Specifications: • No. of cases: 50 • Tissue type: Stomach cancer tissues • No. of spots: 2 spots from each cancer case (100 spots) 4 non-neoplastic spots (4 spots) • Total spots: 104 • Corresponding normal tissues with cancers: No • Diameter: 1. 0 mm Documents : • Product specification: layout, summary of tissue spots • H&E stained images • Detailed pathological information Layout: Page 2 A209: Stomach cancer tissues (formalin fixed) Summary of tissue spots For research use only No. Sex Age Specimen Key Word Grade Stage 1 1(NormalQ C) M 43 stomach signet ring cell carcinoma 2 2(NormalQ ...

Incidence of Stomach Cancer by LA NOTES Incidence of stomach cancer (ICD10 C16) Indirectly standardised registration ratios (SRR) All ages 1998-00 (Pooled) England 1998-00 = 100 (Standard rates are England annual age-specific rates 1998-00) Data are based on ONS population estimates (October 2004 revision). HIGHLIGHTS Over the period 1998-2000 there was a significantly lower incidence of registrations for stomach cancer than England in Dacorum CD and Three Rivers CD FOR MORE INFORMATION Please contact David Edwards, Public Health Intelligence Specialist, PHIU (david.edwards@phi-bedsherts.nhs.uk) PDF created with FinePrint pdfFactory trial version http://www.pdffactory.com Page 2 Source: National Statistics, Compendium of Clinical and Health Indicators (Released 04/05) Incidence of Stomach Cancer (SRR with 95% ...